Pathology & Laboratory Medicine

Warning message

Selective filter "Related Faculty (field_biblio_faculty) (selective)" has limited the amount of total results. Please, review you query configuration.

Publications

Filter By Faculty

Filter by Principal Investigator

2024

Chen C, Fahmy LM, Schreidah CM, Magro CM, Geskin LJ. Febrile Ulceronecrotic Mucha-Habermann Disease Associated With Hemophagocytic Lymphohistiocytosis: A Case Report and Review of the Literature. Am J Dermatopathol. 2024;46(4):238-242.

van den Akker TA, Liu Y-, Liu H, Chapman J, Levine JM, Weinberg OK, et al. Myeloid Proliferations Associated with Down Syndrome: Clinicopathologic Characteristics of Forty Cases from Five Large Academic Institutions. Pathobiology. 2024;91(1):89-98.

O'Neill KA, Dugue A, Abreu NJ, Balcer LJ, Branche M, Galetta S, et al. Relapsing White Matter Disease and Subclinical Optic Neuropathy: From the National Multiple Sclerosis Society Case Conference Proceedings. Neurol Neuroimmunol Neuroinflamm. 2024;11(2):e200194.

Smimmo M, Casale V, Casillo GM, Mitidieri E, Bianca Rd, Bello I, et al. Hydrogen sulfide dysfunction in metabolic syndrome-associated vascular complications involves cGMP regulation through soluble guanylyl cyclase persulfidation. Biomed Pharmacother. 2024;174:116466.

L Medeiros J, Chadburn A, Natkunam Y, Naresh KN. Fifth Edition of the World Health Classification of Tumors of the Hematopoietic and Lymphoid Tissues: B-cell Neoplasms. Mod Pathol. 2024;37(4):100441.

Soderquist CR, Freeman C, Lin W-, Leeman-Neill RJ, Gu Y, Carter MC, et al. Clinical Utility and Reimbursement of Next-Generation Sequencing-Based Testing for Myeloid Malignancies. J Mol Diagn. 2024;26(1):5-16.

Francini E, Nuzzo PV, Fanelli GN. Cell-Free DNA: Unveiling the Future of Cancer Diagnostics and Monitoring. Cancers (Basel). 2024;16(3).

Hsu H, Zanettini C, Coker M, Boudova S, Rach D, Mvula G, et al. Concomitant assessment of PD-1 and CD56 expression identifies subsets of resting cord blood Vδ2 T cells with disparate cytotoxic potential. Cell Immunol. 2024;395-396:104797.

Smithgall MC, Yemelyanova A, Mathew S, Gogineni S, He B, Zhang T, et al. HER2/ ERBB2 Immunohistochemical Expression and Copy Number Status in Ovarian Mucinous Tumors. Int J Gynecol Pathol. 2024;43(2):134-139.

Bidot S, Yin J, Zhou P, Zhang L, Deeb KK, Smith G, et al. Genetic Profiling of African American Patients With Prostatic Adenocarcinoma Metastatic to the Lymph Nodes: A Pilot Study. Arch Pathol Lab Med. 2024;148(3):310-317.